Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvantsHaitao Liu, Ge Liu, Chenliang Zhou et al.|Vaccine|2021Cited by 32
Choline-Retinoic Acid Ionic Liquid [Cho][Ra] as Potential Adjuvant to Enhance Humoral, Cellular, and Mucosal Immune Responses of SARS-CoV-2 RBD AntigenHongyu Zhu, Songping Zhang, Chenghao Gao et al.|Molecular Pharmaceutics|2025Cited by 1